诺和诺德的销售额增长率位列榜首，根本原因还是明星产品司美格鲁肽的爆火出圈。诺和诺德在fiercepharma年度收入排名中连续四年位居第17位后，终于在2023年跃升5位，位居第12位。司美格鲁肽虽然爆火，其中司美格鲁肽注射液Ozempic销售额达139.17亿美元，同比增长60%；司美格鲁肽片剂Rybelsus销售额达27.26亿美元，同...
The pharmaceutical industry continues to generate stellar growth and was estimated to be worth an impressive US$1.6 trillion in 2023 with top 10 pharma companies contributing US$491.84 billion, nearly a third of all revenues. In this blog, we reveal the
The top 20 pharma companies by 2019 revenue 最新排名出炉:2019全球顶级药企Top10! 搞生物医药投资是永远绕不开这些医药巨头的! 中文名字、股票代码和所在国家会特别标出。 1. Johnson & Johnson -强生- JNJ - 美国新泽西州【综合类】 2. Roche - 罗氏 - RHHBY (ADR) - 瑞士 3. Pfizer -辉瑞- PFE - ...
A list of the top 20 pharmaceutical companies in the U.S. is presented. These companies include Pfizer Inc., GlaxoSmithKline and Merck & Co. Inc. It also presents their total market sales for 2006 that reaches $274.87 billion. Data ...
Johnson & Johnson, Eli Lilly and Co, AbbVie Inc, Novo Nordisk AS, and Merck & Co Inc are the top 5 pharmaceutical companies in the world in 2023 by market cap (as of Mar 31, 2023). Comprehensively, the top 10 pharma companies in the world in 2022 had a market cap of $ 2,...
American company Pfizer is one of the top pharma companies globally having a massive customer base globally. Image: flickr.com/photos/matsuyuki/ Founded in 1849 and with headquarters in New York City, USA, Pfizer, a global pharmaceutical company is ranked in the list of top 10 pharmaceutical co...
Showing 10 out of 23 companies. LG Chem Ltd, Celltrion Inc, Yuhan Corp, GC Biopharma Corp, and Chong Kun Dang Pharmaceutical Corporation are the top 5 companies in South Korea in 2021 by revenue. Cumulatively, the top 10 Companies in South Korea generated revenue of $34,925 million, w...
The top 10 pharma companies on the 2022 Fortune 500 list The latest Fortune 500 list is out and Pharma IQ looks at the 10 most profitable pharmaceutical companies TheFortune 500 listhas been released, compiled based on the total revenue businesses made in 2021. It demonstrates that this ...
Exodrug is one of the best and Top 10 PCD pharma Companies in India, dealing in All kind of PCD manufacturing, Third Party Manufacturing, Contract pharma and more.
强生市值的下降主要是由于受到仿制药的冲击。强生的畅销药物Stelara将于明年失去专利保护,而目前已有仿制药处于3期临床阶段。这意味着在未来3-4年内,Stelara将面临仿制药的激烈竞争。根据2021年FiercePharma公布的数据,未来10年强生将会有多款超重磅药物面临专利悬崖问题。